In step with these findings, the complete loss of CHEK1 suppresses chemically induced carcinogenesis, whereas tumor cells with increased levels of CHEK1 may acquire survival advantages due to the ability to resist chemotherapy-induced DNA damage. The gene discussed is CHEK1; the disease is neoplasm.